Brief: Medicinova Inc - Receives Notice Of Intention To Grant For A New Patent Covering Mn-166 (Ibudilast) For The Treatment Of Macular Injury In Europe
17/08/2023 24:02
Aug 17 (Reuters) - MediciNova Inc MNOV.O :
* RECEIVES NOTICE OF INTENTION TO GRANT FOR A NEW PATENT
COVERING
MN-166 (IBUDILAST) FOR THE TREATMENT OF MACULAR INJURY IN EUROPE
Further company coverage: MNOV.O
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake